788 views | 5 years ago
Next-generation sequencing (NGS) is becoming commonplace when seeking a diagnosis for rare genetic disease. This can create a bottleneck when analyzing and interpreting the billions of base pairs and...
34777 views | 5 years ago
See sequencing in a new light with fewer constraints and more possibilities. Introducing the NextSeq 2000. www.Illumina.com For Research Use Only. Not for use in diagnostic procedures. The NextSeq 2000...
5066 views | 5 years ago
Jeff Tsai, a senior scientist in product development at Illumina, and his team set up a study to evaluate how the recently launched AmpliSeq™ for Illumina Custom RNA assay compares to qPCR for analyzing...
1033 views | 5 years ago
Illumina Proactive is our safe, secure instrument monitoring service. When you connect your sequencing system to Proactive, our technical support team can remotely diagnose, troubleshoot, and fix issues...
14606 views | 5 years ago
Since its launch in 2017, the NovaSeq platform has been revolutionary for genomics studies. Hear how the system has continued to evolve to meet customer demands and shape what’s possible in the future....
33826 views | 5 years ago
Learn how noninvasive prenatal testing (NIPT) is making an impact around the world. Hear from the staff at AMES discuss how NIPT, particularly the Illumina VeriSeqTM NIPT solution, has helped meet an...
1271 views | 5 years ago
Dr Eric Topol, director of the Scripps Translational Science Institute, which is playing an important role in the “All of Us” project, discusses the importance of the project, the kind of data being...
1296 views | 5 years ago
Dr. David Bentley, vice president and chief scientist in the clinical genomics research department at Illumina, discusses the history, goals, and milestones of the 100,000 Genome Project conducted in...